MFAP3L predicts tumor microenvironment status, molecular subtypes and clinical benefit in patients with bladder cancer
Abstract Bladder cancer (BLCA), ranking as the tenth most prevalent malignancy globally, imposes a substantial public health and socio-economic challenge. Despite ongoing efforts by urologists to identify novel molecular subtypes and treatment paradigms, the intrinsic heterogeneity of BLCA continues...
Saved in:
| Main Authors: | Guoou Xie, Tiezheng Qi, Yiyan Yao, Dongcai Feng, Weimin Zhou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-11-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-024-77971-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of Immunohistochemistry as a Surrogate Marker in Molecular Subtyping and Classification of Bladder Cancer
by: Tatiana Cano Barbadilla, et al.
Published: (2024-11-01) -
Molecular profiling of bladder cancer xenografts defines relevant molecular subtypes and provides a resource for biomarker discovery.
by: Sharada Mokkapati, et al.
Published: (2025-02-01) -
Immunohistochemistry‐based molecular subtypes of urothelial carcinoma derive different survival benefit from platinum chemotherapy
by: Csilla Olah, et al.
Published: (2025-01-01) -
Molecular subtype of gastric cancer based on apoptosis-related genes reveals differential immune microenvironment and intratumoral microorganisms distribution
by: Xuan Yu, et al.
Published: (2025-01-01) -
Clinicopathological study and molecular subtyping of muscle-invasive bladder cancer (MIBC) using dual immunohistochemical (IHC) markers
by: R. Vaithegi, et al.
Published: (2025-01-01)